Systematic / IUPAC Name: (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1-Hydroxy-1,10a,12a-trimethyl-2,3,3a,3b,4,5,5a,6,7,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-9(1H)-one
ID: Reference1360
Other Names:
Cyclopenta[5,6]naphth[1,2-f]indazol-9(1H)-one, 2,3,3a,3b,4,5,5a,6,7,8,10,10a,10b,11,12,12a-hexadecahydro-1-hydroxy-1,10a,12a-trimethyl-, (1S,3aS,3bR,5aS,10aS,10bS,12aS)-;
(1S,2S,10S,13R,14S,17S,18S)-17-Hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icos-4(8)-en-5-one;
(5,17)-1',2'-Dihydro-17-hydroxy-17-methyl-5'H-androst-2-eno[3,2-c]pyrazol-5'-one;
3'-Hydroxystanazolol
Formula: C21H32N2O2
Class: Therapeutics/Prescription Drugs Sports Doping Drugs
3'-Hydroxystanozolol mass spectral data can be found in a separate interface. The data are manually curated and of the highest quality.
Used Instruments | Q Exactive Orbitrap; Q Exactive Plus Orbitrap |
No. of Spectral Trees | 6 |
No. of Spectra | 511 |
Tandem Spectra | MS1, MS2 |
Ionization Methods | ESI |
Analyzers | FT |
Last Modification | 11/20/2018 1:05:06 PM |
InChI | InChI=1S/C21H32N2O2/c1-19-11-14-17(22-23-18(14)24)10-12(19)4-5-13-15(19)6-8-20(2)16(13)7-9-21(20,3)25/h12-13,15-16,25H,4-11H2,1-3H3,(H2,22,23,24)/t12-,13+,15-,16-,19-,20-,21-/m0/s1 |
InChI Key | SWPAIUOYLTYQKK-YEZTZDHTSA-N |
Canonical SMILES | CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NNC5=O)C |
CAS | 125709399 |
Splash | |
Other Names |
Cyclopenta[5,6]naphth[1,2-f]indazol-9(1H)-one, 2,3,3a,3b,4,5,5a,6,7,8,10,10a,10b,11,12,12a-hexadecahydro-1-hydroxy-1,10a,12a-trimethyl-, (1S,3aS,3bR,5aS,10aS,10bS,12aS)-; (1S,2S,10S,13R,14S,17S,18S)-17-Hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icos-4(8)-en-5-one; (5,17)-1',2'-Dihydro-17-hydroxy-17-methyl-5'H-androst-2-eno[3,2-c]pyrazol-5'-one; 3'-Hydroxystanazolol |